5th Annual Diagnostics Summit

Where: Illumina, 5200 Illumina Way, San Diego, CA

CHI’s 5th Annual Diagnostics Summit will address the increasing number and complexity of evidence development and reimbursement issues facing diagnostics innovators. As innovation continues to evolve and tests advance in their complexity and abundance, medical innovators face numerous challenges in finding clinical evidence to support a test in an increasingly crowded marketplace. The reimbursement of diagnostic tests has become one of the greatest barriers to physician and patient access, and now more than ever before, companies must provide exacting data proving that their product has a greater value and utility than existing test methods. The Summit offers a comprehensive view of the changing landscape of diagnostics reimbursement and brings together the key stakeholders in the field, including senior-level executives from leading firms and academia, along with investors, payers, and policymakers.

View Agenda

Registration is now closed for this event


Agenda Blue

*9:00-11:00 a.m.

Private Reimbursement Briefing for CHI Diagnostics Working Group Members


11:00 a.m.-Noon

Registration and Buffet Luncheon


12:00-12:10 p.m.

Welcome and Opening Remarks

William Rastetter, Ph.D., Chairman of the Board, Illumina


12:10-1:10 p.m.

Pathways for Demonstrating Value and Cost Effectiveness to Payers

• Moderator: Bruce Quinn, M.D., Ph.D., Senior Health Policy Advisor, Foley Hoag (former regional Medicare medical director for the California Part B program)

•Mike Barlow, Vice President, J1 Project Manager, Palmetto

• Matthew Zubiller, Vice President, McKesson Health Solutions


1:10-1:30 p.m.

Reimbursement Reform

• Paul Radensky, M.D., Senior Health Policy Advisor, McDermott Will & Emery


1:30-2:30 p.m.

An Innovation Vision for Diagnostics in 2020

• Kim Popovits, Chairman of the Board, Chief Executive Officer & President, Genomic Health


2:30-3:00 p.m.

Afternoon Networking Break


3:00-4:00 p.m.

Diagnostics Industry Vision 2020: Evidence & Patient-Centered Outcomes

• Moderator & Introductory Presentation: Sean Tunis, M.D., Founder, CEO and President, Center for Medical Technology Policy (former Director of the Office of Clinical Standards and Quality and Chief Medical Officer at the Centers for Medicare and Medicaid Services)

• Bruce Quinn, M.D., Ph.D., Senior Health Policy Advisor, Foley Hoag (former regional Medicare medical director for the California Part B program)

• Dwight Denham, Global Director, Clinical Research, Beckman Coulter

4:00-5:00 p.m.

Genomic Sequencing Vision 2020

• Moderator: Greg Heath, Ph.D., Senior Vice President & General Manager, Diagnostics, Illumina
• Richard Rava, Ph.D., Vice President, Research and Development, Verinata
• Vance Vanier, M.D., Vice President, Global Commercial Operations, Verinata
• Marijke Annis, Market Access And Reimbursement Strategy Consultant, Annis & Associates
• Sean Young, Cystic Fibrosis Patient and Advocate

5:00-6:00 p.m.

Closing Reception


*There will be a private session from 9:00-11:00 am for CHI Diagnostics Working Group members only. Want to become a member of this group? Contact Molly Ingraham ( or 858-456-8884).

Registration is closed for this event.